AGIOS PHARMACEUTICALS INC (AGIO) Stock Income Statement
NASDAQ:AGIO - Nasdaq - US00847X1046 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 37.03M | 36.50M | 26.82M | 14.24M | 0.00 | |||
| Cost Of Goods | 4.62M | 4.17M | 2.88M | 1.70M | N/A | |||
| Gross Profit | 32.41M | 32.33M | 23.94M | 12.54M | N/A | |||
| Operating Expenses | 472.71M | 458.07M | 415.43M | 401.58M | 378.42M | |||
| Research and Development | 305.41M | 301.29M | 295.53M | 279.91M | 256.97M | |||
| Selling, General, and Administrative Expenses | 167.30M | 156.78M | 119.90M | 121.67M | 121.45M | |||
| Operating Income | -440.29M | -425.74M | -391.49M | -389.04M | -378.42M | |||
| Interest Income/Expense | 55.28M | 48.08M | 33.34M | 12.79M | 840.00K | |||
| Other Income/Expense | 6.11M | 6.49M | 6.05M | 6.75M | 14.43M | |||
| Non Recurring Items | N/A | 1.09B | 0.00 | 137.70M | 6.64M | |||
| Income Before Taxes | 710.23M | 717.97M | -352.09M | -231.80M | -356.51M | |||
| Income Tax | N/A | 44.24M | N/A | N/A | N/A | |||
| Net Income | 665.99M | 673.73M | -352.09M | -231.80M | 1.60B | |||
| EBITDA | -434.71M | -420.08M | -384.86M | -380.48M | -369.18M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 11.29 | 11.64 | -6.33 | -4.23 | 26.54 | |||
| Non GAAP EPS | -7.10 | -7.00 | -6.34 | -4.24 | 22.21 | |||
| Statistics | ||||||||
| Gross Profit Margin | 87.52% | 88.59% | 89.26% | 88.06% | N/A | |||
| Profit Margin | 1798.26% | 1845.92% | -1312.63% | -1627.81% | N/A | |||
| Operating Profit Margin | -1188.86% | -1166.47% | -1459.52% | -2732.02% | N/A | |||
All data in USD